cagrilintide novo nordisk shares plunge after CagriSema obesity drug trial disappoints Novo Nordisk's next-gen obesity drug
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12



























